SAB Biotherapeutics, Inc (SABS) insider trading

Every open-market stock purchase and sale by SAB Biotherapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Eddie Joe Sullivan (CEO), $1.5K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent SABS insider trades

DateInsiderTradeValue
Jun 25, 2026Alexandra Kropotova (C-suite exec)Sold (not open market)—
Mar 24, 2026Alexandra Kropotova (C-suite exec)Sold (not open market)—
Feb 3, 2026Eddie Joe Sullivan (President)Bought (not open market)—
Feb 3, 2026Samuel J Reich (CEO)Bought (not open market)—
Feb 3, 2026Lucy To (Insider)Bought (not open market)—
Feb 3, 2026Alexandra Kropotova (C-suite exec)Bought (not open market)—
Feb 3, 2026Christoph Lawrence Bausch (COO)Bought (not open market)—
Jan 5, 2026Rita Jain (Insider)Bought (not open market)—
Jan 5, 2026David Zaccardelli (Insider)Bought (not open market)—
Dec 16, 2025Helen K. Ellias (Insider)Bought (not open market)—
Dec 16, 2025Erick Lucera (Insider)Bought (not open market)—
Dec 16, 2025David Link (Insider)Bought (not open market)—
Dec 16, 2025Jay S Skyler (Insider)Bought (not open market)—
Dec 16, 2025William James Polvino (Insider)Bought (not open market)—
Dec 16, 2025Scott Giberson (Insider)Bought (not open market)—
Dec 11, 2025Alexandra Kropotova (C-suite exec)Sold (not open market)—

Who's trading SABS

Get free alerts when an insider at SAB Biotherapeutics, Inc files a new trade →